Evidence map›Paper›PMID 42369202›Full record

ArticleRespiratory medicine case reports2026

Internal auditory canal metastasis as the only brain lesion in progressive lung adenocarcinoma: Case report and literature review.

Mohamed Yassine Boujnah, Mouna Ben Rejeb, Molka Mezghani, Ghada Abdessatar, Lotfi Kochbati

Abstract readCase Reports
In one paragraph

Article in Respiratory medicine case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Mohamed Yassine BoujnahRadiation Oncology Department, Abderrahmen Mami Hospital, Ariana, 2080, Tunisia.
Mouna Ben RejebRadiation Oncology Department, Abderrahmen Mami Hospital, Ariana, 2080, Tunisia.
Molka MezghaniRadiation Oncology Department, Abderrahmen Mami Hospital, Ariana, 2080, Tunisia.
Ghada AbdessatarRadiation Oncology Department, Abderrahmen Mami Hospital, Ariana, 2080, Tunisia.
Lotfi KochbatiRadiation Oncology Department, Abderrahmen Mami Hospital, Ariana, 2080, Tunisia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Metastases to the internal auditory canal (IAC) are exceptionally rare, especially as a solitary lesion without associated parenchymal brain or leptomeningeal involvement. Lung adenocarcinomas with a signet-ring cell component are aggressive and prone to early dissemination. Case presentation: We report a 64-year-old man with stage IV lung adenocarcinoma with a signet-ring cell component who developed rapidly progressive left-sided facial palsy, vertigo, and hearing loss. Brain MRI revealed a solitary enhancing lesion in the left IAC. Considering the clinical context and rapid symptom progression, a metastatic lesion was suspected. The patient was treated with corticosteroids and radiotherapy. At three-week follow-up, he showed marked improvement in vertigo and hearing, with partial recovery of facial nerve function (House-Brackmann grade III). Conclusion: This case highlights the importance of recognizing rare sites of metastasis in patients with known malignancy. Early diagnosis and prompt treatment with a multidisciplinary approach can lead to meaningful neurological improvement and symptom relief, even in the context of ongoing systemic disease. Clinicians should be alert for IAC metastases when acute cochleovestibular or facial nerve symptoms occur.

Indexed as

Case reportFacial nerve palsyInternal auditory canal metastasisLung cancerRadiotherapySolitary metastasis

Identifiers

PMID42369202
PMCPMC13293743

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.